SMTC Corp. (Nasdaq: SMTX) 50.4% HIGHER; shares are continuing to breakout this week after crossing over the $1 level for the first time since October '08.
Volume continues to be very heavy. Poniard Pharma (Nasdaq: PARD) 24.5% LOWER; downgraded to Sell at Canaccord Adams and downgraded to Market Perform at Leerink Swann.
NeoStem, Inc. (Amex: NBS) 23.3% HIGHER; announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary received approval as of November 6, 2009 from the State...
Post new comment